As of January 2020, it has been reported that one patient with amyotrophic lateral sclerosis, or ALS, has received an investigational drug from BrainStorm Cell Therapeutics and seven patients have received an immunotherapy vaccine under evaluation for glioblastoma under the…   Read more»